Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Expanded_access × Nivolumab × Dermatologic × Clear all

Status

No longer available 2

Sponsor Class

Study Type

Interventional 244 Observational 12 Expanded_access 2

Sponsor

Cancer Type

Dermatologic 2 Tumor-Agnostic 1 Thoracic 1

Conditions

Interventions

trametinib 3 dabrafenib 3 talimogene laherparepvec 2 pembrolizumab 2 Nivolumab 2 Ipilimumab 2 ulixertinib 1 tebentafusp 1 pegilodecakin 1 omaveloxolone 1 methyl 5-aminolevulinate 1 efineptakin alfa 1 cemiplimab 1 balstilimab 1 avelumab 1 aldesleukin 1 Rose Bengal 1 Melphalan 1 HhAntag691 1 Cyclophosphamide 1 Brentuximab Vedotin 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06590480 2025-12-18

RPL-EAP-001

Replimune Inc.

No longer available

Melanoma

NCT02186249 2017-02-08

CheckMate218

Bristol-Myers Squibb

No longer available

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡